BioSpace News Archive

Drug Development

Corthera Initiates Phase II Clinical Trial of Relaxin in Acute Heart Failure

January 8, 2008
·
2 min read
Drug Development

Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension

January 8, 2008
·
4 min read
Biotech Beach

Halozyme Therapeutics, Inc. Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex

January 8, 2008
·
6 min read
Business

Isolagen, Inc. Says CEO Resigned, Names Successor

January 8, 2008
·
3 min read
Business

DRAXIS Health, Inc. Names New President and Chief Executive Officer as well as New Chief Operating Officer

January 8, 2008
·
5 min read
Drug Development

Nektar Therapeutics Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer

January 8, 2008
·
6 min read
BioForest

Nastech Pharmaceutical Company Inc. Receives Notice of Allowance for U.S. Patent Related to Methods for Identifying Cell-Specific Targeting Peptides

January 8, 2008
·
3 min read
Business

CryoLife, Inc. Announces Worldwide License Agreement With Trophic Solutions, LLC

January 8, 2008
·
4 min read
BioCapital

PharmAthene, Inc. and Medarex, Inc. Announce FY 2008 U.S. Congressional Appropriation of up to $1.6 Million for Continued Development of Anthrax Therapeutic Valortim(TM)

January 8, 2008
·
8 min read
Drug Development

Medarex, Inc. Announces Allowance of Investigational New Drug Application for Wholly Owned Fully Human Anti-CD70 Antibody, MDX-1411

January 8, 2008
·
4 min read